Pharma news
Americas
During nearly 30 years as a US Supreme Court justice, Antonin Scalia had the unenviable tasks of ruling on homosexuality, the right to carry hand guns, and abortion. Nevertheless, it was a mystery patent case that proved the most difficult. WIPR looks back at some of the most important IP cases of the past few years and how Scalia voted on them. 18 February 2016
Americas
Galderma Laboratories has successfully avoided three inter partes review petitions being instituted against a patent covering its Oracea (doxycycline, USP) drug, used to treat skin condition rosacea. 17 February 2016
Americas
Accord Healthcare’s attempt to market a generic version of Pfizer’s Tygacil has hit a brick wall after it was accused of infringing three patents. 16 February 2016
Americas
Law firm Steptoe & Johnson has hired Ying Li as a partner in the firm’s intellectual property group in New York. 16 February 2016
Pharma
Eli Lilly has lost the latest round of its patent battle with Allergan centring on the lung cancer drug Alimta. 15 February 2016
Africa
GSK has been fined more than £37 million by the UK government for “anti-competitive conduct” in relation to ‘pay for delay’ deals centring on anti-depressant drug Seroxat. 12 February 2016
Pharma
Law firm Fieldfisher has expanded its life sciences patent litigation and intellectual property practice by hiring Diana Sternfeld, Nicole Jadeja, and Rebecca Baines as partners. 11 February 2016
Pharma
Patient choice is at the heart of plans in the UK to expedite access to pharma-branded medicines in the NHS, but how will innovator companies be affected? LSIPR reports. 11 February 2016
Asia
India’s weak intellectual property enforcement regime and its vague grounds centring on compulsory licences for drugs are reasons it should remain on the “Priority Watch List” in this year’s "Special 301 Report", a pharmaceutical industry association has argued. 9 February 2016
Pharma
Law firm Carpmaels & Ransford has hired David Wilson and Jake Marshall as partners in the firm’s patent litigation and life sciences practices. 9 February 2016